The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis

Rohit Rao, Ralph Salloum, Mei Xin, Q. Richard Lu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

ABSTRACT: G protein-coupled receptors (GPCRs) are critical players in tumor growth and progression. The redundant roles of GPCRs in tumor development confound effective treatment; therefore, targeting a single common signaling component downstream of these receptors may be efficacious. GPCRs transmit signals through heterotrimeric G proteins composed of Gα and Gβγ subunits. Hyperactive Gαs signaling can mediate tumor progression in some tissues; however, recent work in medulloblastoma and basal cell carcinoma revealed that Gαs can also function as a tumor suppressor in neoplasms derived from ectoderm cells including neural and epidermal stem/progenitor cells. In these stem-cell compartments, signaling through Gαs suppresses self-renewal by inhibiting the Sonic Hedgehog (SHH) and Hippo pathways. The loss of GNAS, which encodes Gαs, leads to activation of these pathways, over-proliferation of progenitor cells, and tumor formation. Gαs activates the cAMP-dependent protein kinase A (PKA) signaling pathway and inhibits activation of SHH effectors Smoothened-Gli. In addition, Gαs-cAMP-PKA activation negatively regulates the Hippo pathway by blocking the NF2-LATS1/2-Yap signaling. In this review, we will address the novel function of the signaling network regulated by Gαs in suppression of SHH-driven tumorigenesis and the therapeutic approaches that can be envisioned to harness this pathway to inhibit tumor growth and progression.

Original languageEnglish (US)
Pages (from-to)1325-1330
Number of pages6
JournalCell Cycle
Volume15
Issue number10
DOIs
StatePublished - May 18 2016

Fingerprint

GTP-Binding Proteins
Carcinogenesis
Stem Cells
G-Protein-Coupled Receptors
Cyclic AMP-Dependent Protein Kinases
Neoplasms
Heterotrimeric GTP-Binding Proteins
Ectoderm
Medulloblastoma
Basal Cell Carcinoma
Growth

Keywords

  • Basal cell carcinoma
  • cAMP-dependent PKA
  • G-protein
  • GNAS
  • GPCRs
  • Hedgehog signaling
  • Hippo signaling
  • medulloblastoma
  • Stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis. / Rao, Rohit; Salloum, Ralph; Xin, Mei; Lu, Q. Richard.

In: Cell Cycle, Vol. 15, No. 10, 18.05.2016, p. 1325-1330.

Research output: Contribution to journalArticle

Rao, Rohit ; Salloum, Ralph ; Xin, Mei ; Lu, Q. Richard. / The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis. In: Cell Cycle. 2016 ; Vol. 15, No. 10. pp. 1325-1330.
@article{db4c8df84eff427ea634ac9d6fd12204,
title = "The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis",
abstract = "ABSTRACT: G protein-coupled receptors (GPCRs) are critical players in tumor growth and progression. The redundant roles of GPCRs in tumor development confound effective treatment; therefore, targeting a single common signaling component downstream of these receptors may be efficacious. GPCRs transmit signals through heterotrimeric G proteins composed of Gα and Gβγ subunits. Hyperactive Gαs signaling can mediate tumor progression in some tissues; however, recent work in medulloblastoma and basal cell carcinoma revealed that Gαs can also function as a tumor suppressor in neoplasms derived from ectoderm cells including neural and epidermal stem/progenitor cells. In these stem-cell compartments, signaling through Gαs suppresses self-renewal by inhibiting the Sonic Hedgehog (SHH) and Hippo pathways. The loss of GNAS, which encodes Gαs, leads to activation of these pathways, over-proliferation of progenitor cells, and tumor formation. Gαs activates the cAMP-dependent protein kinase A (PKA) signaling pathway and inhibits activation of SHH effectors Smoothened-Gli. In addition, Gαs-cAMP-PKA activation negatively regulates the Hippo pathway by blocking the NF2-LATS1/2-Yap signaling. In this review, we will address the novel function of the signaling network regulated by Gαs in suppression of SHH-driven tumorigenesis and the therapeutic approaches that can be envisioned to harness this pathway to inhibit tumor growth and progression.",
keywords = "Basal cell carcinoma, cAMP-dependent PKA, G-protein, GNAS, GPCRs, Gα, Hedgehog signaling, Hippo signaling, medulloblastoma, Stem cells",
author = "Rohit Rao and Ralph Salloum and Mei Xin and Lu, {Q. Richard}",
year = "2016",
month = "5",
day = "18",
doi = "10.1080/15384101.2016.1164371",
language = "English (US)",
volume = "15",
pages = "1325--1330",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "10",

}

TY - JOUR

T1 - The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis

AU - Rao, Rohit

AU - Salloum, Ralph

AU - Xin, Mei

AU - Lu, Q. Richard

PY - 2016/5/18

Y1 - 2016/5/18

N2 - ABSTRACT: G protein-coupled receptors (GPCRs) are critical players in tumor growth and progression. The redundant roles of GPCRs in tumor development confound effective treatment; therefore, targeting a single common signaling component downstream of these receptors may be efficacious. GPCRs transmit signals through heterotrimeric G proteins composed of Gα and Gβγ subunits. Hyperactive Gαs signaling can mediate tumor progression in some tissues; however, recent work in medulloblastoma and basal cell carcinoma revealed that Gαs can also function as a tumor suppressor in neoplasms derived from ectoderm cells including neural and epidermal stem/progenitor cells. In these stem-cell compartments, signaling through Gαs suppresses self-renewal by inhibiting the Sonic Hedgehog (SHH) and Hippo pathways. The loss of GNAS, which encodes Gαs, leads to activation of these pathways, over-proliferation of progenitor cells, and tumor formation. Gαs activates the cAMP-dependent protein kinase A (PKA) signaling pathway and inhibits activation of SHH effectors Smoothened-Gli. In addition, Gαs-cAMP-PKA activation negatively regulates the Hippo pathway by blocking the NF2-LATS1/2-Yap signaling. In this review, we will address the novel function of the signaling network regulated by Gαs in suppression of SHH-driven tumorigenesis and the therapeutic approaches that can be envisioned to harness this pathway to inhibit tumor growth and progression.

AB - ABSTRACT: G protein-coupled receptors (GPCRs) are critical players in tumor growth and progression. The redundant roles of GPCRs in tumor development confound effective treatment; therefore, targeting a single common signaling component downstream of these receptors may be efficacious. GPCRs transmit signals through heterotrimeric G proteins composed of Gα and Gβγ subunits. Hyperactive Gαs signaling can mediate tumor progression in some tissues; however, recent work in medulloblastoma and basal cell carcinoma revealed that Gαs can also function as a tumor suppressor in neoplasms derived from ectoderm cells including neural and epidermal stem/progenitor cells. In these stem-cell compartments, signaling through Gαs suppresses self-renewal by inhibiting the Sonic Hedgehog (SHH) and Hippo pathways. The loss of GNAS, which encodes Gαs, leads to activation of these pathways, over-proliferation of progenitor cells, and tumor formation. Gαs activates the cAMP-dependent protein kinase A (PKA) signaling pathway and inhibits activation of SHH effectors Smoothened-Gli. In addition, Gαs-cAMP-PKA activation negatively regulates the Hippo pathway by blocking the NF2-LATS1/2-Yap signaling. In this review, we will address the novel function of the signaling network regulated by Gαs in suppression of SHH-driven tumorigenesis and the therapeutic approaches that can be envisioned to harness this pathway to inhibit tumor growth and progression.

KW - Basal cell carcinoma

KW - cAMP-dependent PKA

KW - G-protein

KW - GNAS

KW - GPCRs

KW - Gα

KW - Hedgehog signaling

KW - Hippo signaling

KW - medulloblastoma

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84969820279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969820279&partnerID=8YFLogxK

U2 - 10.1080/15384101.2016.1164371

DO - 10.1080/15384101.2016.1164371

M3 - Article

C2 - 27052725

AN - SCOPUS:84969820279

VL - 15

SP - 1325

EP - 1330

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 10

ER -